Related Experiment Video

Updated: Jul 13, 2026

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
09:03

Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells

Published on: November 23, 2014

Angiopoietin: a TIE(d) balance in tumor angiogenesis

Winston S N Shim1, Ivy A W Ho, Philip E H Wong

  • 1Research and Development Unit, National Heart Centre, 17 Third Hospital Avenue, Singapore 168752, Singapore. surssnw@nus.edu.sg

Molecular Cancer Research : MCR
|July 20, 2007
PubMed

Insights

Angiopoietins (ANG-1, ANG-2) and TIE-2 signaling impact tumor growth through complex angiogenesis pathways. Understanding their dual roles is key to developing new cancer therapies targeting this pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Vascular Biology

Background:

  • Angiopoietins (ANG-1, ANG-2) and their TIE-2 receptor influence tumor malignancy, including angiogenesis, inflammation, and vascular extravasation.
  • These pathways offer potential for novel cancer treatment strategies, but the precise role of ANG-1 and ANG-2 in tumor angiogenesis is debated.
  • Conflicting findings arise from the complex, complementary, and opposing roles of ANG-1 and ANG-2 in angiogenesis regulation.

Purpose of the Study:

  • To elucidate the multifaceted roles of Angiopoietins (ANG-1, ANG-2) and TIE-2 signaling in tumor angiogenesis.
  • To address the controversies surrounding the regulatory functions of ANG-1 and ANG-2 in tumor development.
  • To clarify the molecular basis of ANG activity for potential therapeutic targeting.

Main Methods:

  • Review of existing literature on Angiopoietins (ANG-1, ANG-2), TIE-2 receptor, and their interactions.
  • Analysis of studies investigating the roles of ANG-1 and ANG-2 in embryonic vascular development and tumor angiogenesis.
  • Examination of evidence for TIE-2-dependent and TIE-2-independent signaling, including integrin receptor functions.

Main Results:

  • ANG-1 is crucial for endothelial-perivascular cell interactions but may also exert anti-angiogenic effects by recruiting perivascular cells.
  • TIE-2 signaling can operate in paracrine and autocrine manners on tumor cells, with the receptor increasingly found on tumor cells.
  • ANG-1 and ANG-2 bind to alpha(5)beta(1) and alpha(v)beta(5) integrins, suggesting broader functions in cellular activities affecting tumor development.

Conclusions:

  • The conflicting findings regarding ANG-1 and ANG-2 in tumor angiogenesis may stem from both TIE-2-dependent and independent activities.
  • Uncertainties in understanding these pathways have hindered the development of clear therapeutic strategies.
  • A deeper comprehension of the molecular mechanisms underlying ANG-1 and ANG-2 activity is essential for advancing novel cancer therapies targeting angiogenesis.

More Related Videos

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies09:03

Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies

Published on: June 30, 2023

Isolation and Culture Expansion of Tumor-specific Endothelial Cells10:15

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

Published on: October 14, 2015

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...